Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Sr.VP Patient Srvcs | September 22, 2026 | September 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date September 22, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Common Stock held in my nameSEC Table I · non-derivative | Direct | 10,725.5448 |
Reported balance
After 2026-09-22 transaction · row 1
1 source rowRow 1 · 2026-09-22 · Sale · Disposed 4,834.0007 · Balance 10,725.5448 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $94.10 · Expires 2029-03-05 | Direct | 4,000 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 4,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $90.62 · Expires 2030-02-24 | Direct | 9,000 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 9,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $157.13 · Expires 2031-02-23 | Direct | 14,000 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 14,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2026 Filed Sep 23, 2026 22:54 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock held in my name | 4,834.0007 | $225.00 | $1,087,650.16 |
DisclosureSEC source: 0001437749-26-031086 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,725.5448 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:14 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-26-013316 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 8,000 shares Expires 2029-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:14 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 2,853 | $173.63 | $495,366.39 |
DisclosureSEC source: 0001437749-26-013316 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,559.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:14 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 4,000 | $94.10 | $376,400.00 |
DisclosureSEC source: 0001437749-26-013316 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,412.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,734 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-26-008849 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,734 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 2,034 | $164.96 | $335,528.64 |
DisclosureSEC source: 0001437749-26-008849 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,412.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 3,734 | $53.94 | $201,411.96 |
DisclosureSEC source: 0001437749-26-008849 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,446.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:34 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,500 | $0.00 Strike: $90.62 | $0.00 |
DisclosureSEC source: 0001437749-26-007216 · rdgdoc.xml · derivative · entry 5 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 13,500 shares Expires 2030-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:34 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 3,159 | $172.83 | $545,969.97 |
DisclosureSEC source: 0001437749-26-007216 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,712.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:34 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 4,500 | $90.62 | $407,790.00 |
DisclosureSEC source: 0001437749-26-007216 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,871.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 22:09 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock held in my name | 1,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006657 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,371.5455 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005659 · rdgdoc.xml · derivative · entry 5 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-02-24 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:43 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 319 | $137.09 | $43,731.71 |
DisclosureSEC source: 0001437749-26-000369 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,289.5455 F1 · shares: On 1/1/2026, 33 1/3 (or 846 shares) of restricted stock originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. The Company withheld 319 shares to pay tax obligations. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 20:41 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-25-036492 · rdgdoc.xml · derivative · entry 4 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 12,000 shares Expires 2029-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 20:41 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 3,140 | $137.95 | $433,163.00 |
DisclosureSEC source: 0001437749-25-036492 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,608.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 20:41 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 4,000 | $94.10 | $376,400.00 |
DisclosureSEC source: 0001437749-25-036492 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,748.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 26, 2025 Filed Jun 26, 2025 21:19 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftShares of Common Stock held in my name | 788 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-021360 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,960.5455 Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-25-020500 · rdgdoc.xml · derivative · entry 6 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,734 Underlying: Common Stock · 7,467 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,734 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-25-020500 · rdgdoc.xml · derivative · entry 5 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,734 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 2,754 | $104.56 | $287,958.24 |
DisclosureSEC source: 0001437749-25-020500 · rdgdoc.xml · nonDerivative · entry 4 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,748.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F4 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 3,734 | $63.96 | $238,826.64 |
DisclosureSEC source: 0001437749-25-020500 · rdgdoc.xml · nonDerivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,502.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 2,511 | $104.56 | $262,550.16 |
DisclosureSEC source: 0001437749-25-020500 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,768.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 3,733 | $53.94 | $201,358.02 |
DisclosureSEC source: 0001437749-25-020500 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,279.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 22:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 946 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006499 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,546.5455 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:47 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 13,500 | $0.00 Strike: $90.62 | $0.00 |
DisclosureSEC source: 0001437749-25-005287 · rdgdoc.xml · derivative · entry 5 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2030-02-24 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:11 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 361 | $107.56 | $38,829.16 |
DisclosureSEC source: 0001437749-25-000217 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,600.5455 F1 · shares: On 1/1/2025, 33 1/3 (or 958 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 361 shares to pay tax obligations. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-24-007892 · rdgdoc.xml · derivative · entry 4 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,467 Underlying: Common Stock · 11,200 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 2,620 | $96.48 | $252,777.60 |
DisclosureSEC source: 0001437749-24-007892 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,961.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 3,733 | $53.94 | $201,358.02 |
DisclosureSEC source: 0001437749-24-007892 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,581.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 12,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-24-006986 · rdgdoc.xml · derivative · entry 4 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-03-05 F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 5, 2025; one-third (1/3) will vest on March 5, 2026; and the final one-third (1/3) will vest on March 5, 2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock held in my name | 1,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006986 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,848.5455 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2025, the next 33 1/3% vesting on 1/1/2026, and the final 33 1/3% vesting on 1/1/2027. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-24-005581 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,734 Underlying: Common Stock · 7,467 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 2,811 | $100.76 | $283,236.36 |
DisclosureSEC source: 0001437749-24-005581 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,830.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 3,733 | $63.96 | $238,762.68 |
DisclosureSEC source: 0001437749-24-005581 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,641.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 02:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 285 | $92.42 | $26,339.70 |
DisclosureSEC source: 0001437749-24-000504 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,908.5455 F1 · shares: On 1/1/2024, 33 1/3 (or 758 shares) of restricted stock originally granted on 2/24/2021, 2/25/2022, and 3/8/2023 vested. The Company withheld 285 shares to pay tax obligations. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-23-033948 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,467 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 3,028 | $87.39 | $264,616.92 |
DisclosureSEC source: 0001437749-23-033948 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,193.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 3,733 | $63.96 | $238,762.68 |
DisclosureSEC source: 0001437749-23-033948 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,221.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:19 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006027 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:19 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock held in my name | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006027 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,488.5455 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:26 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 194 | $59.50 | $11,543.00 |
DisclosureSEC source: 0001437749-23-000354 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,915.5455 F1 · shares: On 1/1/2023, 33 1/3 (or 655 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 194 to pay tax obligations. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 20:42 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock held in my name | 1,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004826 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,109.5455 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:55 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004201 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 22:33 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 67 | $67.94 | $4,551.98 |
DisclosureSEC source: 0001437749-22-000313 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,732.8743 F1 · shares: On 1/1/2022, 33 1/3 (or 229 shares) of restricted stock originally granted on 2/21/2020 and 2/24/2021 vested. The Company withheld 67 shares to pay tax obligations. Read SEC document |
| November 05, 2021 Filed Dec 3, 2021 21:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 6,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-21-027842 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2021 Filed Dec 3, 2021 21:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 5,811 | $76.35 | $443,669.85 |
DisclosureSEC source: 0001437749-21-027842 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,799.8743 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 05, 2021 Filed Dec 3, 2021 21:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 6,000 | $72.94 | $437,640.00 |
DisclosureSEC source: 0001437749-21-027842 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,610.8743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock in my name and my spouse's name | 421 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004190 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610.8743 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2022, the next 33 1/3% vesting on 1/1/2023, and the final 33 1/3% vesting on 1/1/2024. Read SEC document |
| January 01, 2021 Filed Jan 8, 2021 21:47 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock in my name and my spouse's name | 26 | $66.41 | $1,726.66 |
DisclosureSEC source: 0001437749-21-000422 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095 F1 · shares: On 1/1/2021, 33 1/3 (or 88 shares) of restricted stock originally granted on 2/21/2020 vested. The Company withheld 26 shares to pay tax obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:15 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock in my name and my spouse's name | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003498 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121 F1 · shares: Restricted shares subject to a three-year vesting schedule. The shares will vest 33 1/3% on 1/1/2021, 66 2/3% on 1/1/2022, and 100% on 1/1/2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.